Profile of Prescribing Chemotherapy Regimens for High-Risk Acute Leukemia in Children
Profil Peresepan Regimen Kemoterapi Leukemia Akut Risiko Tinggi Pada Anak
DOI:
https://doi.org/10.53342/pharmasci.v8i1.317Keywords:
Cancer, Pediatric ALL, Chemotherapy Drugs, DexamethasoneAbstract
Cancer is one of the non-communicable diseases but is a health problem in the world, including in Indonesia. The results of the 2018 Basic Health Research showed that the prevalence of cancer rose from 1.4% in 2013 to 1.8% in 2018. Acute Lymphoblastic Leukemia (ALL) is a malignant disease characterized by progressive infiltration of immature lymphoid cells in the bone marrow and lymphatic organs. , with leukocyte cells proliferating irregularly and uncontrollably. This study aims to analyze the descriptive profile of prescribing high-risk ALL chemotherapy regimens in children at a hospital in East Surabaya. This study was conducted on inpatients, chemotherapy regimens using the 2018 ALL National Protocol. The protocol consists of 4 phases of chemotherapy, namely the induction, consolidation, intensification and maintenance phases. The results of the study from the drug administration record data, there were 143 pediatric patients with a diagnosis of ALL. high risk from the period July to August 2022. The most widely used drug classification is the glucocorticoid group with use in the induction phase 38,17%, intensification 43,2%, and maintenance 50%. Dexamethasone was the most used generic name 38,17% was used in the induction phase and 43,2% for the intensification phase. The use of ALL chemotherapy doses is Dexamethasone with doses based on the age of the child, the most being 1 mg (97,62%) and 12 mg (88,10%).
References
Mas Ulfa N, Arfiana N. Efektivitas Penggunaan Oral Antidiabetes Kombinasi Glimepiride Dengan Pioglitazone Pada Pasien Dibetes Mellitus Tipe 2. J Pharm Sci. 2020;5(1):1–6.
Kementerian Kesehatan RI. Riskendas 2018. Lap Nas Riskesndas 2018. 2018;44(8):181–222.
Roberts KG. Genetics and prognosis of ALL in children vs adults. Hematol (United States). 2018;2018(1):137–45.
Bambang Permono, Sutaryo, Ugrasena, Endang Widiastuti MA. Lokasi_ Buku Ajar Hematologi-Onkologi Anak. 2005. p. 236–47.
Karen J. Marcdante, Kliegman R, Jenson H, Behrman R. Nelson Ilmu Kesehatan Anak Esensial 6th Edition. 2018. p. 575.
Roganovic J. Acute Lymphoblastic Leukemia in Children | IntechOpen [Internet]. United King Dom London: May 15th, 2013; 2013. p. 39–47. Available from: https://www.intechopen.com/chapters/44135
Tehuteru ES. Gambaran Tingkat Remisi pada Leukemia. Indonesuan J Cancer Vol 5, No4. 2011;5(4):4–7.
IM W, Permono B, IDG U, Ratwita M. Luaran Pengobatan Fase Induksi Pasien Leukemia Limfoblastik Akut pada Anak di Rumah Sakit Umum Dr. Soetomo Surabaya. Sari Pediatr. 2016;12(2):128.
Brown PA, Shah B, Fathi A, Wieduwilt M, Advani A, Aoun P, et al. NCCN Guidelines® insights acute lymphoblastic Leukemia, Version 1.2017 featured updates to the NCCN guidelines. JNCCN J Natl Compr Cancer Netw. 2017;15(9):1091–102.
Lufritayanti A, Fadraersada J, Masruhim MA. Pola Pengobatan Pasien Leukemia Limfoblastik Akut Di Rsud Abdul Wahab Sjahranie Samarinda. 2016;20–1.
Lubis IT, Lubis B, Sembiring T, Rosdiana N, Naaanti S, Siregar OR. Menilai Status Nutrisi Pasien Leukemia Limfoblastik Akut (LLA) Anak. J Cermin Dunia Kedokt [Internet]. 2020;47(2):139–42. Available from: http://www.cdkjournal.com/index.php/CDK/article/view/359
Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6).
SC Nausea. BC Cancer Guidelines for Prevention and Treatment ofChemotherapy-Induced Nausea and Vomiting in Adults. 2022;2022(May 1999):1–8. Available from: www.bccancer.bc.ca/terms-of-use.
DiPiro JT, Yee GC, Posey LM, Stuart T. Haines TDN, Ellingrod V. Pharmacotherapy: A Pathophysiologic Approach, 11e | AccessPharmacy | McGraw Hill Medical. DiPiro, Joseph T. Yee, Gary C. Posey, L.DiPiro, J. T. et al. (2020) Pharmacotherapy: A Pathophysiologic Approach, 11e | AccessPharmacy | McGraw Hill Medical, DiPiro, Joseph T. Yee, Gary C. Posey, L. Michael Stuart T. Haines, Thomas D. Nolin Ellingrod, V. 2020. p. 2672.
Fatikasari AC, Ayu WD, Masruhim MA. Kajian Penggunaan Obat Kemoterapi pada Pasien Leukemia Anak Di RSUD Abdul Wahab Sjahranie Kota Samarinda. Proceeding Mulawarman Pharm Conf. 2018;8(November):111–8.
Lin KT, Wang LH. New dimension of glucocorticoids in cancer treatment. Steroids [Internet]. 2016;111:84–8. Available from: http://dx.doi.org/10.1016/j.steroids.2016.02.019.
Bu H, Lv WJ, Zou YL, Zhang QQ, Liu X, He JY, et al. Intrathecal dexamethasone and methotrexate treatment of neoplastic meningitis from solid tumors. Neuroimmunol Neuroinflammation. 2015;2(3):162.
Utomo FN, Yulistiani Y, Zairina N, Permono B. Methotrexate Use Is Safe in Children With Acute Lymphoblastic Leukemia. Folia Medica Indones. 2017;53(2):144.
